Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 8:10:568.
doi: 10.3389/fonc.2020.00568. eCollection 2020.

Single-Isocenter Volumetric Modulated Arc Therapy vs. CyberKnife M6 for the Stereotactic Radiosurgery of Multiple Brain Metastases

Affiliations

Single-Isocenter Volumetric Modulated Arc Therapy vs. CyberKnife M6 for the Stereotactic Radiosurgery of Multiple Brain Metastases

Rami A El Shafie et al. Front Oncol. .

Abstract

Introduction: Stereotactic radiosurgery (SRS) is becoming more frequently used for patients with multiple brain metastases (BMs). Single-isocenter volumetric modulated arc therapy (SI-VMAT) is an emerging alternative to dedicated systems such as CyberKnife (CK). We present a dosimetric comparison between CyberKnife M6 and SI-VMAT, planned at RayStation V8B, for the simultaneous SRS of five or more BM. Patients and Methods: Twenty treatment plans of CK-based single-session SRS to ≥5 brain metastases were replanned using SI-VMAT for delivery at an Elekta VersaHD linear accelerator. Prescription dose was 20 or 18 Gy, conformally enclosing at least 98% of the total planning target volume (PTV), with PTV margin-width adapted to the respective SRS technique. Comparatively analyzed quality metrics included dose distribution to the healthy brain (HB), including different isodose volumes, conformity, and gradient indices. Estimated treatment time was also compared. Results: Median HB isodose volumes for 3, 5, 8, 10, and 12 Gy were consistently smaller for CK-SRS compared to SI-VMAT (p < 0.001). Dose falloff outside the target volume, as expressed by the gradient indices GI_high and GI_low, was consistently steeper for CK-SRS compared to SI-VMAT (p < 0.001). CK-SRS achieved a median GI_high of 3.1 [interquartile range (IQR), 2.9-1.3] vs. 5.0 (IQR 4.3-5.5) for SI-VMAT (p < 0.001). For GI_low, the results were 3.0 (IQR, 2.9-3.1) for CK-SRS vs. 5.6 (IQR, 4.3-5.5) for SI-VMAT (p < 0.001). The median conformity index (CI) was 1.2 (IQR, 1.1-1.2) for CK-SRS vs. 1.5 (IQR, 1.4-1.7) for SI-VMAT (p < 0.001). Estimated treatment time was shorter for SI-VMAT, yielding a median of 13.7 min (IQR, 13.5-14.0) compared to 130 min (IQR, 114.5-154.5) for CK-SRS (p < 0.001). Conclusion: SI-VMAT offers enhanced treatment efficiency in cases with multiple BM, as compared to CyberKnife, but requires compromise regarding conformity and integral dose to the healthy brain. Additionally, delivery at a conventional linear accelerator (linac) may require a larger PTV margin to account for delivery and setup errors. Further evaluations are warranted to determine whether the detected dosimetric differences are clinically relevant. SI-VMAT could be a reasonable alternative to a dedicated radiosurgery system for selected patients with multiple BM.

Keywords: linear accelerator; multiple brain metastases; palliative; radiosurgery; radiotherapy; robotic radiosurgery; stereotactic; whole-brain radiotherapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Arc arrangement for single-isocenter volumetric modulated arc therapy (SI-VMAT); treatment planning was based on the use of six non-coplanar dual arcs with fixed couch angles of 0, 25, 45, 90, 315, and 335°.
Figure 2
Figure 2
Multiplanar visualization of dose distribution compared between CyberKnife radiosurgery and single-isocenter volumetric modulated arc therapy (SI-VMAT) for a representative case; gross tumor volume (GTV) delineated in dark red. SI-VMAT, single-isocenter volumetric modulated arc therapy.
Figure 3
Figure 3
Dose exposure of the healthy brain for different dose levels between 3 and 12 Gy to represent dose falloff for all targets within one treatment plan (A) or for the individual target (B); boxes represent Q1–Q3 around the median. CK, CyberKnife; SI-VMAT, single-isocenter volumetric modulated arc therapy; VX Gy, volume receiving X Gy.

References

    1. Weller M. Leitlinien für Diagnostik und Therapie in der Neurologie: Hirnmetastasen und Meningeosis Neoplastica. DGN (2015). p. 1–42. Available online at: http://www.awmf.org/leitlinien/detail/ll/030-060.html
    1. National Comprehensive Cancer Network Central Nervous System Cancers V1. 2019. (2016). p. 123. Available online at: https://www.nccn.org/professionals/physician_gls/pdf/cns.pdf
    1. Yamamoto M, Serizawa T, Shuto T, Akabane A, Higuchi Y, Kawagishi J, et al. . Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol. (2014) 15:387–95. 10.1016/S1470-2045(14)70061-0 - DOI - PubMed
    1. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, et al. . Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. (2009) 10:1037–44. 10.1016/S1470-2045(09)70263-3 - DOI - PubMed
    1. Aoyama H, Tago M, Kato N, Toyoda T, Kenjyo M, Hirota S, et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys. (2007) 68:1388–95. 10.1016/j.ijrobp.2007.03.048 - DOI - PubMed